Sawai Group Holdings Co., Ltd. (TYO: 4887)
Japan
· Delayed Price · Currency is JPY 2,151.00
-12.50 (-0.58%)
Dec 30, 2024, 3:45 PM JST
Sawai Group Holdings Revenue
Sawai Group Holdings had revenue of 43.54B JPY in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to 177.34B, down -7.31% year-over-year. In the fiscal year ending March 31, 2024, Sawai Group Holdings had annual revenue of 176.86B, down -11.72%.
Revenue (ttm)
177.34B
Revenue Growth
-7.31%
P/S Ratio
1.58
Revenue / Employee
50.93M
Employees
3,482
Market Cap
262.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
| Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
| Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
| Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
| Mar 31, 2020 | 182.54B | -1.80B | -0.98% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Otsuka Holdings | 2,269.56B |
| Terumo | 986.67B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |